=46rom: Linda Carlton <[log in to unmask]>
To: [log in to unmask]
Subject: http://ourworld.compuserve.com/homepages/chronicwellness/dhe=
a.htm
Date: Tue, 17 Jun 1997 01:26:42 -0700

Colloidal DHEA - LiquidLightning DHEA Plus=99

Information Sheet

DHEA Quotes , DHEA FAQ's, Colloid FAQ's, Home Page

Blood levels of DHEA in men and women peak around the age of 20, and =
it is
the only hormone that declines in a linear fashion in both sexes. As =
such it
is one of the most reliable markers of aging. By age 80, blood levels=
 of
DHEA are only 5% of what they were at age 20.

You may have read or heard about wild yam supplements or        [DHEA=
 Chart]
crystalline sources of DHEA. Both must travel through the
digestive system and lose much of their efficacy. Colloidal DHEA is
administered sublingually and composed of particles that are ultrafin=
e;
0.0001 to 0.001 microns in diameter. This assures the best absorption=
 and
use by the body. These ultrafine particles do not dissolve but remain
suspended in a suitable electrically charged liquid (demineralized wa=
ter).
DHEA is present in ionized form which makes it biologically available=
 at an
instant!

DHEA has been shown to be effective against Arteriosclerosis, Cancer,=
 AIDS,
Diabetes, Alzheimer's, Rheumatoid Arthritis, Lupus, Multiple Sclerosi=
s,
Chronic Fatigue Immune Dysfunction Disease, Parkinson's Disease, and
Obesity!

An innovative and revolutionary health and wellness company has just
introduced a new, colloidal form of DHEA (dehydroepiandrosterone), wh=
ich is
5 to 20 times more effective than capsules, pills, tinctures or table=
ts!
Colloids are composed of particles that are extremely ultrafine and
ultralight -- 0.0001 to 0.01 microns in diameter-so as to assure the =
best
absorption and use by the body. These particles do not dissolve, but =
remain
suspended in electrically charged demineralized water. Colloidal solu=
tions
are far superior to capsules since the body must convert crystalline =
DHEA to
a colloidal state before it can be utilized at the cellular level. In
addition, over 50% of the capsule form may be destroyed in the digest=
ive
tract. Colloidal DHEA is taken sublingually, thereby bypassing the di=
gestive
tract altogether and assuring optimal absorption into the blood strea=
m.

Life Extension/Vitality

A team of scientists at the University of California, San Diego, has
completed a year-long study of the anti-aging effects of DHEA on a gr=
oup of
16 middle-aged to elderly people with some intriguing results. The pa=
tients
who received DHEA reported a 75 percent increase in their overall
well-being. Specifically, patients reported an improved ability to co=
pe with
stress, greater mobility, less joint pain and better quality sleep. T=
he DHEA
group was also found to have higher concentrations of insulin growth =
factor,
a compound that spurs the immune system and normally decreases with a=
ge.

Other studies showed that when DHEA was fed to mice it increased thei=
r life
expectancy by a third. The mice seemed younger and had a lower incide=
nce of
the typical diseases of aging. DHEA reduced the risk of breast, colon=
, and
lung cancer in mice. Other studies have found that DHEA can reduce th=
e risk
of liver, skin, and lymphatic tissue cancers.

Cardiovascular Disease

In a 1986 study published in 'The New England Journal of Medicine',
researchers at UC San Diego measured DHEA levels in 242 men 50 to 79 =
years
old, then tracked their health for 12 years. Men whose initial levels=
 were
higher than 140 mcg were less than half as likely to have died of hea=
rt
disease by the end of the study, even when researchers took into acco=
unt
such factors as smoking and cholesterol levels. Those with the highes=
t
levels fared the best: For every 100-point increase, there was a 48% =
drop in
heart disease risk and a 36% decrease in death by any cause. A 1988 s=
tudy
was done at John Hopkins in which rabbits with severe atherosclerosis=
 where
treated with DHEA. They had an almost 50% reduction in plaque size.

Dr. Barrett-Conner and her researchers concluded that one of DHEA's
protective functions may be to inhibit the enzyme glucose-6-phosphate
dehydrogenase, which triggers the production of fatty acids and chole=
sterol.
When DHEA levels fall, the enzyme system accelerates, increasing prod=
uction
of both fatty acids and cholesterol. This obviously could promote obe=
sity
and atherosclerosis. Therefore DHEA seems to protect against diabetes=
 and
obesity, and it appears to do so by inhibiting an enzyme (glucose 6
phosphate dehydronase) which limits fat synthesis. It acts as a therm=
ostat
that regulates the furnace and inhibits the conversion of carbohydrat=
es to
fat in the body.

Breast Cancer

In a study of 5,000 women, it was discovered that those with DHEA blo=
od
levels less that 10% of the normally expected amount for their age gr=
oup all
developed breast cancer and died of the disease. These women had subn=
ormal
urinary excretion of DHEA as long as nine years prior to the developm=
ent of
the disease.

Dr. Arthur Schwartz, a researcher at Philadelphia's Temple University=
, found
that women with breast cancer have lower DHEA levels and concurrent
increases of G6PD (glucose 6 phosphate dehydrogenase), which promotes=
 cancer
as well as fat production.

Fat Loss

"There isn't any question," Schwartz says, "DHEA is a very effective
anti-obesity agent." In mice, it gives almost a fifty percent reducti=
on in
excess fat. In fact, DHEA appears to be the first substance that when
laboratory tested, caused the loss of fat (as opposed to mere weight =
loss
due to the breakdown of primary lean muscle tissue or fluid loss) wit=
hout
changing eating habits. DHEA increases the body's ability to transfor=
m food
into energy, and not only burns off excess fat, but prevents fat from
accumulating in the first place.

In a 1977 study Terrence Yen, a bio-chemist at Eli Lilly, found that =
when
DHEA is fed to obese mice, their weight drops significantly, even wit=
hout
any change in diet or exercise.

Diabetes

A certain inbred strain of mice has a genetic disorder that causes th=
em to
develop diabetes. Their pancreatic beta cells, those cells in the pan=
creas
that make insulin, are also spontaneously destroyed during the course=
 of
their lifetime by yeast/fungus. When this strain of mice was given 0.=
4% DHEA
in their diet, the diabetes was rapidly reversed and the beta cells w=
ere
preserved. In a study of other animals without this genetic disorder,=
 DHEA
reduced the severity of diabetes resulting from administering the
diabetes-inducing chemical, streptozotocin.

Rhematoid Arthritis

In a study of 49 postmenopausal women with rheumatoid arthritis, a co=
ndition
associated with osteoporosis, DHEA levels were significantly lower th=
an in
healthy controls. DHEA levels were reduced to a greater extent in wom=
en
taking corticosteroids for their arthritis than in those who were not=
. That
finding is not surprising since administering these drugs is known to=
 reduce
the levels of adrenal androgens such as DHEA. In this group of 49 wom=
en,
DHEA levels correlated significantly with bone mineral density of the=
 neck
of the femur ( a bone in the hip) and the spine. The serum level of D=
HEA was
able to predict bone mineral density, even after corticosteroid thera=
py was
taken into account. This study suggests that DHEA might be of benefit=
 to
people with rheumatoid arthritis.

Supplementing with DHEA might prevent the osteoporosis that so often
develops in individuals with rheumatoid arthritis, particularly in th=
ose who
are taking corticosteroids. In addition, DHEA may impact positively o=
n the
arthritic process itself. According to Dr. Lamson, who has given DHEA=
 to
several arthritic patients with low serum levels of DHEA, this treatm=
ent
often relieves pain and morning stiffness, increases strength and red=
uces
the need for anti-inflammatory medication. In a study of 45 postmenop=
ausal
women being treated with corticosteroids, administering DHEA resulted=
 in an
increased sense of well-being, with no side effects.

Menopause/Osteoporosis

It has been shown that menopause is associated with a reduction in DH=
EA
levels. In one study, the average plasma level of DHEA (ng/100ml) was=
 542 in
premenopausal women, 197 in postmenopausal women, and only 126 in wom=
en
whose ovaries had been surgically removed. In a group of women betwee=
n the
ages of 55 and 85 years, there was a significant correlation between =
serum
levels of DHEA and bone density of the vertebral spine. In other word=
s,
women with higher levels of DHEA had greater bone mass than those wit=
h lower
DHEA levels.

Memory Loss

Increasing DHEA in elderly patients appears to improve memory functio=
n.
Research by medical doctor Eugene Roberts of City of Hope Medical Cen=
ter
conducted on 31 elderly volunteers indicated that the volunteers who =
took
DHEA experienced less memory loss that volunteers who given a placebo=
. At
New York University School of Medicine, psychiatrist Kenneth Bonnet r=
eported
that DHEA replacement therapy on test mice resulted in better memory.=
 When
Dr. Bonnet treated middle aged and old mice with DHEA, their retentio=
n and
recall skills, which earlier had been much lower that those of young =
mice,
now increased to the same levels as the young mice.

The French endocrinologist, Etienne-Emile Baulieu, inventor of the ab=
ortion
pill RU 486, is wagering that doses of DHEA will sharpen the mind eve=
n as
they protect the body. The hormone helps brain cells grow in the lab,=
 seems
to improve rodents' short-term memory, and has even shown some effect=
 in
humans. "We've already seen some correlation between DHEA levels and =
mental
acuity in older people," says Baulieu.

Alzheimer's Disease

The Alzheimer's patients studied by Dr. C.R. Merril of the Laboratory=
 of
Biochemical Genetics at the National Institute of Mental Health in Be=
thesda,
Maryland, showed DHEA levels 48% lower than the control group of
non-Alzheimer's patients. We know that DHEA is a precursor building b=
lock of
estrogen. In April, 1994, 'Prevention Magazine' quoted Annila Paganin=
i-Hill,
professor of preventive medicine at the University of Southern Califo=
rnia,
as saying that increased estrogen may be related to a decrease in the=
 risk
of developing Alzheimer's in women.

AIDS

In the November 1991 issue of 'The Journal of Infectious Disease,' Dr=
.
William Regelson demonstrated that people with HIV virus do not suffe=
r from
full-blown AIDS until their adrenal output of DHEA drops. Blood sampl=
es from
HIV-positive patients at the University of California at San Francisc=
o were
tested for both DHEA and T-cell levels, the immune cells that are pri=
marily
affected with AIDS. Men with low levels of DHEA had double the risk o=
f
full-blown AIDS compared to men with normal DHEA levels.

Parkinson's Disease

Patients with diseases of the central nervous system such as senility=
 of
Parkinsonism, who have dangerously low serum blood levels of DHEA, ar=
e
highly responsive to substitution therapy with DHEA. This quite in ke=
eping
with the latest surgical method of treatment for Parkinson's patients=
. Brain
surgeons have implanted slices of adrenal gland tissue into the brain=
. This
transplanted tissue, which is taken from the diseased patient's own a=
drenal
gland, or from embryonic adrenal tissue, escapes destruction by the i=
mmune
system, and produces a partial temporary improvement in Parkinson's
patients. If DHEA is administered there is considerable improvement i=
n
Parkinson's patients, without the risk and side effects of brain surg=
ery.

Author's note: DHEA is produced in the adrenal gland!

Lupus (Systemic Lupus Erythematosus)

Stanford University Medical Center investigators Ronald F. van Vollen=
hoven,
M.D., Ph.D., Edgar G. Engleman, M.D., and James L. McGuire, M.D., rep=
orted
results of their 3-month trial in 28 women with mild to moderate lupu=
s in
whom DHEA or placebo was added to their usual medical regimen.

In each of four outcome measures, patient self-assessment, physician
assessment, a composite index of disease activity and prednisone dose=
, mean
value in women treated with DHEA improved while those on placebo were=
 stable
or worsened. When placebo patients were subsequently given DHEA for t=
hree
month after the trial, their symptoms improved similarly to those pat=
ients
who received the treatment during the blinded phase of the trial. The=
 only
side-effect seen more commonly in DHEA-treated patients was acne, whi=
ch
responded to topical agents.

DHEA Quotes , DHEA FAQ's, Colloid FAQ's,

Order Form

Home Page
---------------------------------------------------------------------=
-------

Copyright =A91996-97 by Chronic Wellness International =99

Last Updated 5/10/97